Cancer immunotherapy\nhas turned out to be a revolutionary treatment to fight against this largest\ngroup of diseases in the world. The artificial stimulation of the immune system\nenhances the natural ability of the body to fight against cancer. The field on\nimmunotherapy shows a great potential in treating a wide range of types of\ncancers. Over 8,000 cancer immunotherapy experiments are taking place in\nclinical trials along with which includes rapid development of biomarkers. The\nsmart and effective immunotherapy is already transforming cancer treatment\napproach while biomarkers, in addition, will help to identify appropriate\ntherapies that suit the best to a particular patient. It will also be helpful\nin monitoring the response of the treatment. <\/p>\n\n\n\n
Biomarkers certainly\nhave the potential to provide useful insight into the treatment approach. Hence\nit comes as no surprise that it\u2019s being part of many phases of the clinical\ntrial process. Here are the four trends in cancer immunotherapy biomarkers that\ncan make a headway in improving the response rate of patients.<\/p>\n\n\n\n
Combination of\ntretaments:<\/strong><\/p>\n\n\n\n A recent research\nshows that instead of a particular treatment, a combination of multiple\ntretaments is more effective and can lead to positive results. Hence more\nemphasis is given to developing combination treatments. Studies have analyzed\nthat PD-1 in conjunction with CTLA-4 inhibitors used as the therapy for\nmelanoma has shown positive results in a considerable number of patients. It is\nalso predicted that enhancement in tissue biomarkers and extensive study of\nimmune response can effectively help in developing more safe and positive\nresulting treatments for cancer. Combination treatments can be a powerful\ngame-changer, certainly, watch out for that.<\/p>\n\n\n\n Relation of tumor\nmutation burden to the response rate:<\/strong><\/p>\n\n\n\n At a World Conference\non Lung Cancer in 2017, researchers presented a data that revealed high TMB may\nlead to better outcomes as compared to low or medium TMB. The prediction is\nirrespective to the type of treatment. TMB which means Tumor Mutation Burden is\na term that evaluates the number of mutations in a particular area of the\ngenetic material. Higher the TMB, higher are chances of positive outcome in\nresponse to immunotherapy. The response rate is significantly higher in\npatients who received a combination of different therapies with high TMB as\ncompared to those patients who received single therapy. <\/p>\n\n\n\n Cutting-edge\ntechnology for the development of biomarker:<\/strong><\/p>\n\n\n\n The genomic and\nproteomic technologies in combination with bioinformatic tools have shown the\ncapability of the simultaneous breakdown of thousands of molecules which are\nbiological in nature. The new tumor signatures can relevantly be founded with\nthe help of such leading-edge technologies which are significant in creating\nprecision medicines and analyzing personalized cancer therapy. Just to name a\nfew, whole-exome sequencing, T-cell receptor clonality sequencing technology,\ngene expression profiling, mass cytometry are some of the innovative techniques\nthat are bringing the change in cancer treatment. <\/p>\n\n\n\n PD-1\/PD-L1 immune\ncheckpoint blockade <\/strong><\/p>\n\n\n\n Studies suggest that\ncheckpoint blockade is most likely to be an effective way. However, these\nimmune checkpoint inhibitors are only effective on a few sets of patients.\nBiomarkers for discovering the response to PD-1\/PD-L1 comprise of\nmicrosatellite instability (MSI), D-L1 expression and tumor mutation burden\n(TMB). Studies also further suggest that there is a need of examination of the\npotential utilization of PDL1 developments as a biomarker for immune checkpoint\nblockade response. <\/p>\n\n\n\n There is a strong\nrequirement for identifying predictive and prognostic markers so as to find\ntherapies and precision medicine for a particular patient. Cancer Immunotherapy\nBiomarkers development creates a golden opportunity is discovering a treatment\nthat\u2019s appropriate for a specific patient, it can surely bring a revolution in\nthe fight against cancer. <\/p>\n","protected":false},"excerpt":{"rendered":" Cancer immunotherapy has turned out to be a revolutionary treatment to fight against this largest group of diseases in the world. The artificial stimulation of the immune system enhances the natural ability of the body to fight against cancer. The field on immunotherapy shows a great potential in treating a wide range of types of cancers. Over 8,000 cancer immunotherapy experiments are taking place in clinical trials along with which includes rapid development of biomarkers. The smart and effective immunotherapy is already transforming cancer treatment approach while biomarkers, in addition,…<\/p>\n","protected":false},"author":2,"featured_media":68,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[17,15,16],"_links":{"self":[{"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/posts\/67"}],"collection":[{"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/comments?post=67"}],"version-history":[{"count":1,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/posts\/67\/revisions"}],"predecessor-version":[{"id":69,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/posts\/67\/revisions\/69"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/media\/68"}],"wp:attachment":[{"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/media?parent=67"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/categories?post=67"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/tags?post=67"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}